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Purpose: Primary care practices are an ideal setting for reducing national smoking rates because >70% of
smokers visit their physician annually, yet smoking cessation counseling is inconsistently delivered to pa-
tients. We designed and created a novel software program for handheld computers and hypothesized that it would
improve clinicians’ ability to provide patient-tailored smoking cessation counseling at the point of care.
Methods: A handheld computer software program was created based on smoking cessation guide-
lines and an adaptation of widely accepted behavioral change theories. The tool was evaluated using a
validated before/after survey to measure physician smoking cessation counseling behaviors, knowledge,
and comfort/self-efﬁcacy.
Results: Participants included 17 physicians (mean age, 41 years; 71% male; 5 resident physicians)
from a practice-based research network. After 4 months of use in direct patient care, physicians were
more likely to advise patients to stop smoking (P  .049) and reported an increase in use of the “5 As”
(P  .03). Improved self-efﬁcacy in counseling patients regarding smoking cessation (P  .006) was
seen, as was increased comfort in providing follow-up to patients (P  .04).
Conclusions: Use of a handheld computer software tool improved smoking cessation counseling
among physicians and shows promise for translating evidence about smoking cessation counseling into
practice and educational settings. (J Am Board Fam Med 2013;26:116–125.)
Keywords: Behavioral Counseling, Health Information Technology, Practice-based Research, Smoking Cessation
One third of the world’s adult population smoke cig-
arettes (1.1 billion people), resulting in nearly 5
million deaths annually, with projections of 10 million
annual deaths if current global smoking patterns con-
tinue.
1 Previous declines in smoking rates have stalled
over the past 5 years,
2 and nearly half of the United
States’ 45.3 million current smokers are expected to
die prematurely as a result of smoking.
A recent Institute of Medicine report calls for im-
plementing successful cessation methods and ap-
proaching smoking as a disease management issue,
3
yet it has been difﬁcult to translate these recommen-
dations into clinical practice. Excellent evidence-
based guidelines for smoking cessation counseling
have been available for more than 2 decades, and an
update was published in 2008.
4,5 Distribution of pa-
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National Cancer Institute spent nearly $10 million
distributing guidelines in the 1980s, with little impact
on physician practices.
6 Wide dissemination of Public
Health Service guidelines to all U.S. physicians in
2000 also led to no appreciable difference in rates of
physicians asking patients about tobacco use or coun-
seling them to quit.
7
Clinicians in primary care have the potential to
impact national smoking rates; 70% of smokers visit
their physician annually.
8 Despite having these guide-
lines for smoking cessation available, physicians con-
tinue to perform poorly in delivering smoking cessa-
tion counseling to their patients. Goldstein et al.
9
found that a majority of community-based primary
care physicians reported asking (67%) and advising
(74%) their patients about smoking, but rates of as-
sisting (35%) or arranging (8%) follow-up were much
lower. Several additional studies have conﬁrmed these
low rates of recommended physician smoking cessa-
tion counseling,
10–16 demonstrating the need for in-
novative, dynamic, and accessible methods to trans-
late and disseminate smoking cessation counseling
information to clinicians.
Personal digital assistants (PDAs) and smartphones
(eg, iPhones and Android-powered phones) can be
useful in helping clinicians apply information at the
point of care. We have previously piloted the delivery
of basic smoking cessation guidelines and prescribing
information on these devices, with promising re-
sults.
17,18 PDA-based interventions with carefully
synthesized information and interactive processes
have the potential to mitigate time, training, and
conﬁdence barriers that frequently are cited as rea-
sons for lack of preventive services being delivered in
primary care settings.
19–23
To improve smoking cessation counseling in
primary care, we designed and developed the Mod-
ular Lifestyle Intervention Tool (MLIT), a novel
software program for hand-held computers that
expanded on our previous work by providing a
scripted, algorithmic approach to smoking cessa-
tion counseling. We hypothesized that the MLIT
would improve clinicians’ ability to provide pa-
tient-tailored counseling at the point of care.
Methods
Participants
This study was approved by the University of Vir-
ginia Institutional Review Board. Clinicians were
recruited from 4 practices afﬁliated with the Vir-
ginia Practice Support and Research Network,
which includes University of Virginia academic
practices and community-based practices in central
Virginia. This study was open to approximately 31
faculty and 24 resident family medicine and inter-
nal medicine physicians at 4 different practice-
based research network practices. Physicians all had
their own PDAs and used the tool in practice for a
period of 4 months. Routine smoking cessation
counseling and pharmacotherapy for patients was
not widely covered by payers at the time of this
trial. An electronic medical record was not in use
during the study period, although laboratory and
imaging results were retrievable via computer.
Study Instruments
A before/after survey instrument was designed and
validated to measure self-reported physician behavior,
knowledge, and comfort/self-efﬁcacy related to coun-
seling patients about smoking cessation (Appendix 1).
The survey also included items on obesity and over-
weight counseling, which will be reported separately.
Content validity was assessed by 6 experts in the ﬁelds
of behavioral change and smoking cessation. In addi-
tion, this instrument was adapted from a similar, pre-
viously validated survey in which face and content
validity were assessed and the reliability of subscales
was measured.
17 Because this previous measure
showed good reliability for the physician behavior
(Cronbach 0.74) and physician comfort subscales
(Cronbach 0.71), the majority of these items
were retained. Additional knowledge questions were
added to the current survey to address low reliability
in the previous survey (Kuder–Richardson formula
20  0.23). Demographic variables included hand-
held computer literacy, age, and sex.
Use of the Tool at the Point of Care
Use of the tool was monitored via data usage logs
that were saved on the device and downloaded to a
desktop computer at the end of the study. Activity
reports included total sessions, average pages viewed
per session, unique pages viewed per session, page
contents, date and time of each use, and length of
time per use.
Statistics
Self-reported physician behavior, knowledge, and
comfort/self-efﬁcacy related to counseling patients
about smoking cessation were analyzed for differ-
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intervention. Binary data were analyzed with Mc-
Nemar 
2 test; all other data were analyzed with
Wilcoxon signed rank test. Statistical signiﬁcance
was assumed at 0.05. All analyses were con-
ducted with S-Plus 6.1 (Insightful Corp., Seattle,
WA) and SPSS version 19 (IBM, Chicago, IL).
Creation of the Clinical Decision Support Tool
A multidisciplinary software development group
(SDG) was convened and included a family medicine
physician with experience in smoking cessation, 2
general internists with expertise in motivational inter-
viewing (MI) and smoking cessation, and a clinical
psychologist with expertise in behavioral change. The
SDG adapted the Public Health Service’s Clinical
Practice Guideline for Treating Tobacco Use and
Dependence
4 and 3 behavioral health theories—the 5
As,
24 Stages of Change (SOC),
25 and MI
26—into a
logical and navigable format. The SDG used an iter-
ative process, meeting weekly for approximately 12
1-hour sessions. The software was designed by the
software programmer for both Windows CE and
Palm software platforms.
18
Description of the MLIT
The SDG developed a theoretical framework inte-
grating the 5 As, SOC, and MI, which we have de-
scribed previously.
27 The “Ask” component of the 5
As was operationalized by encouraging practices to
adopt smoking status as a vital sign, but it was not
included in the MLIT software. The “Advise” com-
ponent was integrated into the tool by including in-
formation on MI pertinent to physician counseling.
The “Assess” and “Assist” components were opera-
tionalized using SOC and MI theories. The MLIT
uses 2 questions on one screen to guide the identiﬁ-
cation (assessment) of the patient’s current “stage” of
change then directs the clinician to “Assist” by pro-
viding staged-based information and MI-based scripts
promoting smoking cessation (see Figures 1 to 5 in
Appendix 2, available online) At the end of the script,
MLIT prompts the clinician to “Arrange” follow-up
and provides a list of both local and national resources
(Figure 6 in Appendix 2, available online).
Results
Twenty-four physicians enrolled in the study (17
faculty and 7 residents), and 17 participants (71%)
completed the trial. Before/after surveys were avail-
able for all 17 participants (5 residents); however,
data usage results were only available for 14 physi-
cians (58%; 4 residents), representing all 4 practice
sites. Missing data resulted from hardware failures
leading to data loss. Practice locations included 2
large, urban teaching sites (one family medicine
teaching clinic with approximately 11 providers,
one internal medicine teaching clinic with approx-
imately 13 providers); and 2 rural university-afﬁli-
ated practices (both family medicine practices, one
with 4 physicians and one with 3 physicians). Mean
age of the participants was 41 years (range, 28–57
years), and they had spent a mean of 20 years in
practice. Of the participants, 71% were men, and
71% reported their hand-held computer literacy as
intermediate on a 3-point scale (from novice to
expert). Physicians from all 4 separate practices
participated in the study. Table 1 contains results
discussed in the subscale sections that follow.
Physician Comfort and Self-efﬁcacy With Smoking
Cessation Counseling
Physicians reported increased self-efﬁcacy in smoking
cessation counseling (before intervention, 4.3 of 7.0
[range, 2–6]; after intervention, 5.0 of 7.0 [range,
4–6]; Wilcoxon signed rank test, P  .006) and in-
creased comfort in following patients once they had
initiated a smoking cessation plan (before interven-
tion, 4.9 of 7.0 [range, 2–7]; after intervention, 5.6 of
7.0 [range, 4–7]; P  .04). Reliability of subscales was
measured using Cronbach  and found to be 0.70 for
the comfort/self-efﬁcacy subscale.
Physician Smoking Cessation Counseling Behavior
Smoking cessation counseling behaviors were mea-
sured before and after the intervention using 18
questions (Cronbach 0.54). Five questions
measured use of the 5 As (ask, advise, assess, assist,
and arrange; Cronbach 0.64); another 4 ques-
tions identiﬁed general counseling behavior (Cron-
bach 0.58); and 3 asked about stage-speciﬁc
interventions, use of motivational interviewing, and
use of the Public Health Service guidelines (Cron-
bach  0.170). Finally, 6 questions asked about
use of pharmacotherapy (patch, inhaler, nicotine
gum, nasal spray, Zyban [GlaxoSmithKline, Re-
search Triangle Park, NC] and Commit lozenges
[GlaxoSmithKline]; Cronbach 0.56). Perfor-
mance on the summed 5 As behaviors improved
after use of the tool (mean before intervention,
11.0  1.8 [range, 7–15]; mean after intervention,
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was seen in advising smokers to quit smoking (P 
.049), and there was a nonsigniﬁcant increase in
assisting smokers with quitting (P  .09). General
counseling behaviors did not change after use of
the tool (eg, How often do you counsel? How often
do you provide smoking cessation information?
How often do you use smoking cessation pharma-
cotherapy? How often do you refer smokers for
counseling?). More physicians used stage-speciﬁc
interventions, MI, and the Public Health Service
guidelines after use of the tool, but these changes
were not statistically signiﬁcant. There were no
signiﬁcant changes in pharmacotherapy use; how-
ever, an increase in the use of Commit lozenges
after use of the tool was observed (P  .07).
Physician Knowledge About Smoking Cessation
Overall smoking cessation knowledge was un-
changed (before intervention, 75.2  12.7% cor-
rect; after intervention, 76.9  10.9% correct; P 
NS). When the subscales for stage-based classiﬁca-
tion and interventions were examined (Cronbach
0.65), we found no statistically signiﬁcant in-
crease in knowledge. However, there was an in-
crease in smoking cessation pharmacotherapy
knowledge (before intervention, 50  19.8% cor-
rect; after intervention, 64.7  23.5% correct; P 
.053; Cronbach 0.04).
Physician Use of Tool at Point of Care
Clinicians who completed the study and had valid
use data (n  14) had a total of 71 sessions (average
of 5 sessions per user). The majority of physicians
used the tool during clinic hours (93%), and the
average session lasted 21 minutes. Additional data
on tool use and content accessed are detailed in
Tables 2 and 3.
Discussion
We created a novel clinical decision support tool to
assist clinicians with smoking cessation counseling.
Use of this tool was associated with increased use of
the 5 As well as increased physician self-efﬁcacy and
comfort in providing smoking cessation counseling.
Table 1. Changes in Physician Comfort Levels with Smoking Cessation Counseling and Self-Reported Counseling
Behaviors Before and After the Intervention (n  17)
Before Intervention After Intervention P
Comfort/self-efﬁcacy subscale (mean score)*
Effective counseling of patients 4.3 5.0 .006
Comfort following patients who are attempting to quit 4.9 5.6 .04
Physician smoking cessation counseling behavior subscale (mean score)
†
Summed 5 As behavior 11.0 11.8 .03
Advising smokers to quit 2.5 2.7 .05
Assisting smokers with quitting 2.0 2.2 .09
Physician performance, % (n)
Use of stage-speciﬁc interventions 71 (12) 100 (17) Unavailable
Use of motivational interviewing 82 (14) 94 (16) .48
Use of Public Health Service guidelines 12 (2) 29 (5) .39
Use of nicotine lozenges 18 (3) 47 (8) .07
Physician smoking cessation knowledge subscale
Overall knowledge (%) 75.2 76.9 NS
Smoking pharmacologic treatment knowledge 50 64.7 .05
*Based on a 7-point Likert scale, with 1  very uncomfortable and 7  very uncomfortable.
†Based on a 4-point Likert scale with 0  never, 1  sometimes, 2  often, and 3  always.
NS, not signiﬁcant.
Table 2. Use of the Modular Lifestyle Intervention Tool
(MLIT) at the Point of Care
Clinicians Completing Study
With Valid Log Files
(n  14)
Total sessions with MLIT tool 71
Average sessions per user 5 (1–29)
Total pages accessed 275 (1–86)
Average pages per session 20 (1–87)
Total time accessed (min) 289 (1–118)
Average session length (min) 21 (1–29)
Data provide as n (range).
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works. The 5 As provides a broad framework for
behavioral counseling and its adoption is recom-
mended by the U.S. Preventive Services Task
Force. Physicians can vary the intensity and com-
plexity of the behavior change counseling, match-
ing their efforts to factors individual to each pa-
tient. The framework is simple to understand,
adaptable to most behavioral health risks, and pro-
vides a consistent approach with demonstrated ef-
ﬁcacy.
4,24 The SOC model has been shown to be an
effective approach to smoking cessation counsel-
ing.
25 This model tailors the counseling to the
individual patient’s readiness to change, making the
process less confrontational and more efﬁcient.
The fundamental postulate of SOC is that effective
behavioral change is best facilitated by sequentially
moving individuals from one stage to the next using
stage-matched intervention strategies. Although we
recognize the potential limitations of SOC to pre-
dict individual behavior,
28–30 it is a model with
which many physicians are familiar and is an im-
portant reminder to consider a patient’s readiness
for any particular message or intervention.
31,32 Al-
though the principles of SOC were used to concep-
tualize and assess patients’ readiness for change, MI
techniques formed the basis of the scripted interviews
used by physicians to move patients along the SOC
continuum. MI promotes relationship building and
attempts to motivate patients by exploring and resolv-
ing their ambivalence about changing their behavior.
Strong evidence supports the use of this approach for
effective smoking cessation counseling in primary
care settings,
33 and there is signiﬁcant literature sup-
porting its use for other health behaviors.
34,35 To our
knowledge, our study is the ﬁrst formal integration of
the SOC, MI, and the 5 As approaches into a singular
clinical decision support tool for use by physicians at
the point of care.
Comparison With Prior Work
Physicians report lack of training, skill, and time as
barriers to being effective behavioral counselors.
19–23
Simple clinical decision support tools available for use
at the point of care can potentially overcome these
barriers and may also serve as an educational tool.
Our study demonstrates that even short-term expo-
sure (4 months) to a clinical decision support tool can
improve physicians’ conﬁdence and self-efﬁcacy in
smoking cessation counseling and can change physi-
cian counseling behaviors. There also is emerging
evidence that hand-held computers may be an effec-
tive modality for improving patient outcomes in of-
ﬁce-based settings. Studies of hand-held computers in
these settings have shown improved treatment by
physicians for asthma,
36 otitis media
37 and upper re-
spiratory infections.
38 Another study showed poten-
tial reductions in adverse drug events.
39
Limitations
We studied a small sample of physicians, the ma-
jority of whom rated their hand-held computer
literacy as intermediate. Physicians also needed to
own a PDA to participate. Because of the small
sample size and purposeful sampling, external gen-
eralizability is not assured, and larger trials in var-
ious medical settings should be conducted. In ad-
dition, because of the high level of computer
literacy, study participants may have been more
willing to use a clinical decision support tool be-
cause of their previous experience in using hand-
held technology. This should also be replicated in
groups that have varying levels of computer liter-
acy. However, increasing use of electronic medical
records by all physicians and smartphones by the
newest generation of physicians will likely diminish
this limitation over time. Our use of before/after
study design is a further limitation because it can-
not control for secular trends, test/retest perfor-
mance, and other potential confounders inherent in
this design. We did not ﬁnd an overall improve-
ment in knowledge scores among users of the
Table 3. Modular Lifestyle Intervention Tool (MLIT)
Content Accessed During Intervention
Speciﬁc smoking content accessed (n  223)
Stages of change 64%
Motivational interviewing 4%
Smoking dependency assessment (Fagerstrom) 9%
Pharmacotherapy 14%
Smoking cessation resources 9%








Pharmacotherapy Accessed (n  30)
First-line smoking cessation drugs 63%
Second-line smoking cessation drugs 37%
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group of physicians; many of them were already
knowledgeable regarding smoking cessation coun-
seling, the Public Health Service guidelines, and
pharmacological treatment options before their use
of the tool. In addition, changes in physician be-
havior were based on self-report and, because of
the limited scope of this study, no measures of
clinical outcomes were obtained. Last, some of the
scales used to measure differences in physician
comfort, behaviors, and knowledge did not have
high internal reliability and would beneﬁt from
further psychometric analysis and development be-
fore being deployed in larger trials.
Lessons Learned and Next Steps
This new tool was accepted by physicians and used
in clinical practice. In addition, use by a large num-
ber of residents and length of time of each use
indicate potential as an educational intervention.
Since there is increasing interest in and evidence
for using this approach with other health care pro-
viders in patient-centered medical homes, we pro-
pose to test this approach with nurses, nurse prac-
titioners, physician assistants, and other members
of the health care team, as well as in residency
education. Our institutional and practice environ-
ment has shifted toward the use of a full-featured
electronic medical record, and therefore the use of
this tool on PDAs and smartphones has become
less relevant; however, the content is ideal for use
with electronic medical records. To continue quick
versioning the software content and applying it to
other behavior changes, we have found it necessary
to partner with a software development company
with expertise and capacity to support rapidly
evolving clinical and technical demands. We cur-
rently are developing and testing tools for use in
alcohol misuse, drug abuse, and obesity. We aim to
develop a full-featured behavior change platform
that can be used with nearly any hardware (eg,
desktop personal computers, tablet computers,
smartphones, and PDAs).
Conclusions
Hand-held computers can provide portable clinical
decision support at the point of contact between
patients and clinicians and may be useful as educa-
tional tools. They are widely available, relatively
inexpensive, and easy to access and operate. In
addition, clinicians report using them for profes-
sional use in high numbers (45% to 85%, depend-
ing on the setting).
40 Our study demonstrates that
these tools can improve physician conﬁdence and
self-efﬁcacy in smoking cessation counseling. Larger
controlled trials in community-based and educational
settings are needed to determine whether such tools
can increase clinician knowledge and ultimately af-
fect patient outcomes. If these results are con-
ﬁrmed, there seems to be a signiﬁcant opportunity
to enhance the translation of guidelines into clinical
practice through this approach, ultimately beneﬁt-
ing patients by helping physicians address impor-
tant unhealthy behaviors such as smoking.
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122 JABFM March–April 2013 Vol. 26 No. 2 http://www.jabfm.orgAppendix A: Before/After Survey Measuring Physician Behavior, Attitudes, Comfort, and
Knowledge About Smoking Cessation Counseling
Questionnaire 1: Modular Lifestyle Intervention Tool (MLIT): A Handheld Tool to Assist Clinicians in Providing
Patient-Tailored Counseling at the Point of Care
Date: _______
ID#__________________
1. How would you describe your hand-held computer literacy? (Please circle one.)
a. Novice b. Intermediate c. Expert
2. What is your current age? _______ years
3. What is your sex? (Please circle one.) M F
4. How many years have you been in practice? _______ years
5. In a typical week of practice, what percentage of your patients are smokers? (Please circle one.)
a. 0–25% b. 26% to 50% c. 51% to 75% d. 76% to 100% e. No idea
6. Does your practice have a system to record smoking status at every visit? (Please check one.)
▫ Yes ▫ No ▫ Not Sure
7. Do you have an understanding of the 6 stages of change as deﬁned by Prochaska and DiClemente (precontemplation,
contemplation, preparation, action, maintenance, relapse)? (Please circle one.)
a. Total understanding b. Some understanding c. No understanding d. Not sure
8. Do you ever use stage-speciﬁc interventions with your patients? (Please check one.)
▫ Yes ▫ No ▫ Not sure
9. Do you ever use motivational interviewing techniques with your patients? (Please check one.)
▫ Yes ▫ No ▫ Not Sure
10. How often do you:
a. Ask patients if they smoke? (Please circle one.)
a. Always b. Often c. Sometimes d. Never
b. Advise smokers to quit?
a. Always b. Often c. Sometimes d. Never
c. Assess smokers’ willingness to quit?
a. Always b. Often c. Sometimes d. Never
d. Assist smokers in their attempt to quit?
a. Always b. Often c. Sometimes d. Never
e. Arrange follow-up with patients who want to quit?
a. Always b. Often c. Sometimes d. Never
11. How often do you:
a. Provide counseling for patients who want to quit smoking?
a. Always b. Often c. Sometimes d. Never
b. Provide information on quitting such as pamphlets, videos, or online resources?
a. Always b. Often c. Sometimes d. Never
c. Recommend pharmacotherapy for your patients who want to quit smoking?
a. Always b. Often c. Sometimes d. Never
d. Provide referral for your patients to seek assistance with smoking cessation?
a. Always b. Often c. Sometimes d. Never
12. When you counsel patients regarding their behavior change efforts, do you feel you have sufﬁcient time available?
a. Always b. Often c. Sometimes d. Never e. I do not counsel
patients
13. If you recommend pharmacotherapy pertaining to smoking behaviors, what do you recommend? (Check all that apply.)
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14. Are you familiar with the Public Health Service (PHS) Clinical Practice Guidelines on treating tobacco use?
▫ Yes ▫ No ▫ Not sure
15. Do you currently utilize the PHS Guidelines with your patients?
▫ Yes ▫ No ▫ Not sure
16. Do you feel you are effective in counseling patients regarding smoking cessation?
0





17. How comfortable are you in appropriately utilizing the pharmacological therapies available to aid smokers with quitting
smoking?
0





18. How comfortable are you following patients who have initiated a smoking cessation plan to help them sustain their plan?
0





19. Which of the following statements regarding Zyban® (Bupropion SR) is false?
a. The usual dose is 150 mg twice per day.
b. The medication should be started at least 1 week before quitting.
c. This medication can be used during pregnancy if other approaches to smoking cessation have failed.
d. Recommended treatment length is 7 to 12 weeks.
e. This medication can be used by breastfeeding mothers who are attempting to quit smoking.
20. Which of the following is not a contraindication to using Zyban (bupropion SR):
a. Known seizure disorder
b. Chronic renal insufﬁciency
c. Concurrent use of monoamine oxidase inhibitors
d. Bulimia or anorexia nervosa
e. Allergy to bupropion or its ingredients
21. Which of the following statements regarding Commit lozenges is false?
a. Patients should not chew or swallow the lozenges
b. Consuming the lozenge too fast can lead to heartburn or indigestion
c. Patients should stop using the lozenge after 12 weeks
d. Patients may use up to 15 lozenges per day initially
e. Some common contraindications include mouth problems, persistent indigestion, or severe sore throat
22. Which of the following statements is true?
a. Clonidine and Nortriptyline are recommended second-line agents for smoking cessation according to the Public Health
Service Guidelines on Treating Tobacco Use and Dependence
b. Clonidine should be initiated at least 10 to 14 days before quitting smoking to achieve therapeutic dosing
c. Nortriptyline should only be used for 4 to 6 weeks in smoking cessation
d. Nortriptyline can be initiated shortly before quitting smoking (i.e., 3–5 days)
e. Clonidine should be started at 0.1 mg bid and titrated up to 0.3 mg bid to achieve maximum therapeutic effect
23. You have a patient who comes in to talk with you about setting a smoking quit date. He would like to quit smoking before






24. For the patient in question 23, the least appropriate intervention at this time would be:
a. Set a quit date with the patient
b. Talk about brief coping skills such as avoiding and/or altering triggers and substituting with gum or candy
c. Discuss pharmacotherapy and offer it as a treatment option
d. Try to build self-efﬁcacy with the patient by using strategies such as proximal goal setting and offering a menu of change
e. Determine the patients smoking dependency in order to determine the best treatments
Continued
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25. Your next patient quit smoking last week. She comes in for her recommended 1-week follow-up to discuss her increasing






26. For the patient in question 25, the least appropriate intervention at this time would be:
a. Give the patient plenty of positive reinforcement and lots of encouragement
b. Explore the decisional balance with the patient
c. Discuss maintenance and side effects of pharmacotherapy
d. Continue to support self-efﬁcacy with the patient such as making sure there is social support and a “buddy system”
e. Schedule a follow-up visit at 1 month
27. You have a complete physical examination scheduled for one of your patients. On his chart, you note that he quit smoking 5






28. For the patient in question 27, the least appropriate intervention at this time would be:
a. Discuss “difﬁcult times” and how the patient is handling them
b. Discuss relapse prevention, for example, avoiding triggers, altering triggers, and cognitive strategies
c. Discuss the decisional balance again with the patient
d. Discuss the importance of treating quitting as a lifetime enterprise; patients can still relapse even after 5 years
e. Discuss “slip management” with the patient and what to do if they have a single slip
28. Your patient smokes one pack per day and is thinking about attempting to quit smoking in the next 6 months. which stage of






29. For the patient in question 28, the least appropriate intervention at this time would be:
a. Re-explore the decisional balance with the patient to reinforce this concept
b. Try to build self-efﬁcacy with the patient by using strategies such as proximal goal setting and offering a menu of change
c. Encourage the patient to consider setting a quit date
d. Discuss the different nicotine replacement therapies and their side effects
e. Schedule a follow-up visit in 1 month
30. You have a follow-up visit with a patient recently discharged from the hospital after her ﬁrst acute myocardial infarction. She
continues to smoke one pack of cigarettes per day. She angrily answers “No” when asked if she has any plans to quit smoking.






31. For the patient in question 30, the least appropriate intervention at this time would be:
a. Avoid arguing with her
b. Ask her to enroll in a tobacco cessation program
c. Ask her, “What are the positive things you get from smoking?”
d. Acknowledge the difﬁculties of quitting
e. Schedule a follow-up visit
Questions about obesity/overweight counseling and treatment are omitted from this version of the survey.
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Lifestyle Intervention Tool (MLIT) Tool
Figure 1. Stage of change tool in MLIT used to guide
clinician to appropriate stage-based intervention.
Figure 2. Initial “contemplation” content screen.
Figure 3. Appropriate stage-based interventions for
clinicians to use with patients in contemplation stage.
Figure 4. Physician prompts for addressing “decisional
balance” with patient in contemplation stage.
doi: 10.3122/jabfm.2013.02.110078 Smoking Cessation Using Health Intervention Tool E1Figure 5. Physician prompts for “supporting self-
efﬁcacy” of patients.
Figure 6. National and local resources listed to prompt
physicians to arrange follow-up with patients.
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